Abstract
C12H16N4O11Mn, triclinic, P1̄ (no. 2), a = 7.7186(3) Å, b = 9.8439(3) Å, c = 11.6084(3) Å, α = 104.288(3)°, β = 94.024(3)°, γ = 97.365(3)°, V = 842.93(5) Å3, Z = 2, Rgt(F) = 0.0322, T = 291 K.

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Data collection and handling.
| Crystal: | Colorless block |
| Size: | 0.35 × 0.29 × 0.27 mm |
| Wavelength: | Mo Kα radiation (0.71073 Å) |
| μ: | 0.86 mm−1 |
| Diffractometer, scan mode: | Supernova, φ and ω-scans |
| θmax, completeness: | 25°, >99% |
| N(hkl)measured, N(hkl)unique, Rint: | 14394, 2880, 0.031 |
| Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 2709 |
| N(param)refined: | 260 |
| Programs: | CrysAlisPRO [1], SHELX [2], OLEX2 [3] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
| Atom | x | y | z | Uiso*/Ueq |
|---|---|---|---|---|
| Mn1 | 0.77286(4) | 0.58068(3) | 0.66268(3) | 0.02699(13) |
| O1 | 0.48902(19) | 0.56463(16) | 0.69480(13) | 0.0313(4) |
| O1W | 1.0479(2) | 0.58940(18) | 0.64937(15) | 0.0400(4) |
| H1WA | 1.0690 | 0.5886 | 0.5779 | 0.060 |
| H1WB | 1.0812 | 0.5135 | 0.6602 | 0.060 |
| O2 | 0.27823(19) | 0.47657(17) | 0.78836(14) | 0.0361(4) |
| O2W | 0.8310(2) | 0.76948(17) | 0.81111(15) | 0.0442(4) |
| H2WA | 0.7394 | 0.7823 | 0.8469 | 0.066 |
| H2WB | 0.8530 | 0.8425 | 0.7844 | 0.066 |
| O3 | 0.2524(2) | 0.32374(18) | 0.92858(15) | 0.0367(4) |
| H3 | 0.2641 | 0.3726 | 0.8810 | 0.055 |
| O3W | 0.6959(2) | 0.38549(16) | 0.51154(13) | 0.0323(4) |
| H3WA | 0.6204 | 0.3995 | 0.4558 | 0.048 |
| H3WB | 0.6351 | 0.3171 | 0.5357 | 0.048 |
| O4 | 0.4184(2) | 0.21081(18) | 1.02283(15) | 0.0412(4) |
| O5 | 0.7062(3) | 0.69583(19) | 0.53944(16) | 0.0488(5) |
| O6 | 0.9500(2) | 0.7691(2) | 0.46879(18) | 0.0502(5) |
| O7 | 1.0381(2) | 0.9113(2) | 0.33200(19) | 0.0545(5) |
| H7 | 1.0039 | 0.8596 | 0.3740 | 0.082 |
| O8 | 0.9176(3) | 1.0317(2) | 0.21897(17) | 0.0541(5) |
| N1 | 0.7366(2) | 0.44486(18) | 0.79222(15) | 0.0254(4) |
| N2 | 0.7219(2) | 0.30659(19) | 0.91609(15) | 0.0277(4) |
| N3 | 0.5053(2) | 0.83313(18) | 0.41636(15) | 0.0273(4) |
| N4 | 0.5862(2) | 0.97669(17) | 0.30359(15) | 0.0260(4) |
| C00I | 0.5676(3) | 0.4253(2) | 0.82085(17) | 0.0217(4) |
| C1 | 0.4356(3) | 0.4940(2) | 0.76408(18) | 0.0248(5) |
| C2 | 0.8237(3) | 0.3718(2) | 0.8507(2) | 0.0302(5) |
| H2 | 0.9426 | 0.3659 | 0.8471 | 0.036 |
| C3 | 0.5547(3) | 0.3395(2) | 0.89804(17) | 0.0230(4) |
| C4 | 0.7874(3) | 0.2182(3) | 0.9899(2) | 0.0456(6) |
| H4A | 0.9089 | 0.2122 | 0.9799 | 0.068 |
| H4B | 0.7203 | 0.1249 | 0.9655 | 0.068 |
| H4C | 0.7758 | 0.2600 | 1.0724 | 0.068 |
| C5 | 0.4030(3) | 0.2856(2) | 0.95499(18) | 0.0274(5) |
| C6 | 0.7866(3) | 0.7626(2) | 0.4770(2) | 0.0330(5) |
| C7 | 0.6822(3) | 0.8401(2) | 0.40923(18) | 0.0233(4) |
| C8 | 0.4534(3) | 0.9170(2) | 0.35272(19) | 0.0283(5) |
| H8 | 0.3379 | 0.9332 | 0.3428 | 0.034 |
| C9 | 0.7360(3) | 0.9280(2) | 0.33806(17) | 0.0243(4) |
| C10 | 0.9066(3) | 0.9620(2) | 0.2921(2) | 0.0357(5) |
| C11 | 0.5663(4) | 1.0811(3) | 0.2346(2) | 0.0472(7) |
| H11A | 0.5850 | 1.0414 | 0.1530 | 0.071 |
| H11B | 0.6509 | 1.1645 | 0.2680 | 0.071 |
| H11C | 0.4499 | 1.1056 | 0.2377 | 0.071 |
Source of material
All chemicals were used as obtained without further purification. The mixture of 4,5-dicarboxyimidazole (H2mdci; 0.1 mmol, 17.1 mg), triazole (trz) (0.1 mmol, 7.0 mg) Mn(OAc)2⋅4H2O (0.2 mmol, 49.1 mg), and H2O (6.0 mL) was placed in 23 mL Teflon-lined autoclave, heated to 120 °C for 3 days, and then slowly cooled down. Colourless block-shaped crystals were obtained.
Comment
Design and construction of supramolecular chemistry have stimulated the interests of chemists over the past few decades, owing to their intriguing variety of architectures and their potential applications [4], [5], [6]. Polydentate organic ligands are good candidates for the construction of supramolecular complexes for their diversity in the coordination modes. The imidazole-(bi)carboxylic ligands with the manifold N– and O-donors are good candidates, which finally aggregate to various supramolecular architectures. Very interesting and promising results have been obtained by using imidazole dicarboxylic ligands as efficient linkers [7], [8]. To the best of our knowledge, plenty of transition metal-H2dci (4,5-dicarboxyimidazole) complexes have been documented so far [9], [10], [11]. In comparison with H2dci (4,5-dicarboxyimidazole), 4,5-dicarboxyl-1-methyl-1H-imidazole (H2mdci), as a derivative of H2dci, can probably provide the potential to enrich the unpredictable and interesting structural and functional diversities of network structures [10], [12]. In this paper, we have chosen the 4,5-dicarboxyl-1-methyl-1H-imidazole (H2mdci) as a bridging ligand, whereas 1,2,4-triazole (trz) as auxiliary ligand, successfully constructing new coordination complexes.
The asymmetric unit contains a crystallographically distinct Mn(II) cation, two uncompletely deprotonated Hmdci anions and three water molecules. The Mn1 is octahedrally coordinated by one N atom and two oxygen atoms from two Hmdci ligands, respectively, and three oxygen atoms from three water molecules. Two carboxylate groups from two different Hmdci ligands, the imidazolyl from Hmdci ligand and one water molecule comprise the equatorial basal plane. The other two water ligands occupy the apical sites. All the Mn—O bond lengths are in the range of 2.1078(16)–2.2406(15) Å, and the Mn—N bond distance is 2.2545(17) Å. One Hmdci ligand adopts a-k2N,O coordination mode. The other Hmdci ligand adopts monodentate coordination. The 4-position carboxylate O atom from each Hmdci ligand remains uncoordinated.
The H-bonding interactions play an important role in forming the resultant three-dimensional framework. There exist two hydrogen bonds in the complex O7⋯O6: 2.439(3) Å; O3⋯O2: 2.476(2) Å. There are many intermolecular hydrogen bonds that link the adjacent mononuclear units to a three-dimensional supramolecular network.
Funding source: National Natural Science Foundation of China
Award Identifier / Grant number: 21571093
Funding statement: This work was supported by the National Natural Science Foundation of China (No. 21571093).
References
Oxford Diffraction Ltd, CrysAlisPRO, Abingdon, Oxfordshire, England (2006).Search in Google Scholar
Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar
Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Search in Google Scholar
Gale, P. A.; Sessler, J. L.; Steed, J. W.: Supramolecular chemistry–introducing the latest web themed issue. Chem. Commun. 47 (2011) 5931–5932.10.1039/c1cc90048jSearch in Google Scholar
Harmon, K. M.; Gill, S. H.; Rasmussen, P. G.; Hardgrove Junior, G. L.: Inter- and intramolecular hydrogen bonding effects on the structure, solubility, and reactivity of 4,5-dicarboxyimidazoles. J. Mol. Struct. 478 (1999) 145–154.10.1016/S0022-2860(98)00669-3Search in Google Scholar
Janczak, J.; Kubiak, R.: Pyrazine control of the supramolecular chemistry of iron(II) and cobalt(II) phthalocyanines. CrystEngComm 12 (2010) 3599–3606.10.1039/c003440aSearch in Google Scholar
Das, S.; Karmakar, S.; Saha, D.; Baitalik, S.: A combined experimental and DFT/TD-DFT investigation of structural, electronic, and cation-induced switching of photophysical properties of bimetallic Ru(II) and Os(II) complexes derived from imidazole-4,5-dicarboxylic acid and 2,2′-bipyridine. Inorg. Chem. 52 (2013) 6860–6879.10.1021/ic302566pSearch in Google Scholar PubMed
Gu, Z. G.; Liu, Y. T.; Hong, X. J.; Zhan, Q. G.; Zheng, Z. P.; Zheng, S. R.; Li, W. S.; Hu, S. J.; Cai, Y. P.: Construction of metal-imidazole-based dicarboxylate networks with topological diversity: thermal stability, gas adsorption, and fluorescent emission properties. Cryst. Growth Des. 12 (2012) 2178–2186.10.1021/cg2002095Search in Google Scholar
Fang, R. Q.; Zhang, X. M.: Diversity of coordination architecture of metal 4,5-dicarboxyimidazole. Inorg. Chem. 45 (2006) 4801–4810.10.1021/ic052099mSearch in Google Scholar PubMed
Plieger, P. G.; Ehler, D. S.; Duran, B. L.; Taylor, T. P.; John, K. D.; Keizer, T. S.; Mark McCleskey, T.; Burrell, A. K.; Kampf, J. W.; Haase, T.; Rasmussen, P. G.; Karr, J.: Novel binding of beryllium to dicarboxyimidazole-based model compounds and polymers. Inorg. Chem. 44 (2005) 5761–5769.10.1021/ic050680cSearch in Google Scholar PubMed
Fang, R. Q.; Zhang, X. H.; Zhang, X. M.: A NaCl-like metal-organic framework constructed by unprecedented tetrahedral Cd4O6 and Cd5O6 units. Cryst. Growth Des. 6 (2006) 2637–2639.10.1021/cg060408tSearch in Google Scholar
Smith, T. S.; Root, C. A.; Kampf, J. W.; Rasmussen, P. G.; Pecoraro, V. L.: Reevaluation of the additivity relationship for vanadyl-imidazole complexes: correlation of the EPR hyperfine constant with ring orientation. J. Am. Chem. Soc. 122 (2000) 767–775.10.1021/ja991552oSearch in Google Scholar
©2018 Liu Guang-Zhen et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Articles in the same Issue
- Cover and Frontmatter
- Crystal structure of 2-amino-4-(2,4-dinitrophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo-pyran, C18H16N4O6
- Crystal structure of catena-poly[(μ3-5-carboxy-2-(pyridin-4-yl)benzoato-κ5O,O′:O′′,O′′′:O′′′)(1,10-phenanthroline-κ2N,N′)cadmium(II)], C100H60N12O16Cd4
- Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C19H18N2O6
- Crystal structure of 1-{4-[(2-hydroxy-5-methyl benzylidene)amino]phenyl}ethanone O-ethyl-oxime, C18H20N2O2
- Crystal structure of bis{4-methyl-2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O)}copper(II), C36H38CuN4O4
- Crystal structure of bis{5-methoxy-2-((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}nickel(II), C34H34N4NiO6
- Crystal structure of poly[μ8-3-carboxyphthalat-κ8-O:O1,O1,O1:O2:O3,O3:O4)silver(I)], C9H4Ag2O6
- Crystal structure of 2-((E)-((4-((E)-1-(hydroxyimino)ethyl)phenyl)iminio)methyl)-5-methoxyphenolate, C16H16N2O3
- Crystal structure of (E)-1-(4-(((E)-2-hydroxy-3-methoxybenzylidene)amino)phenyl)ethan-1-one oxime, C16H16N2O3
- The crystal structure of 2-(tert-butyl)-4-chloro-6-phenyl-1,3,5-triazine, C13H14Cl1N3
- Crystal structure of (6,6′-(((((2-aminoethyl)azanediyl)bis(ethane-2,1-diyl))bis(azanylylidene))bis(methanylylidene))bis(2,4-dichlorophenolato)-κ6N,N′,N′′,N′′′,O,O′)cadmium(II) – ethanol – water (1/1/1), C22H28CdCl4N4O4
- Crystal structure of 6-chloro-N-methylpyrimidin-4-amine, C5H6ClN3
- Synthesis and crystal structure of bis{((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)-2-naphtholato-κ2N,O}nickel(II), C40H34N4NiO4
- Crystal structure of (E)-2-(4-bromophenyl)ethenesulfonyl fluoride (C8H6BrFO2S)
- Synthesis and crystal structure of 2,2′-ethylenedioxybis(benzimide)-2,2′-bis[O-(1-propyloxyamide)]oxime-4,4′,6,6′-tetrachlorodiphenol, C36H34Cl4N4O8
- Crystal structure of bis(N-(1-(pyrazin-2-yl)ethylidene)nicotinohydrazonato-κ3N,N′,O)cadmium(II) – methanol (1/1), C26H28N10O4Zn
- Crystal structure of diaqua-(N-(1-(pyrazin-2-yl)ethylidene)nicotinohydrazonato-κ3N,N′,O)-bis(nitrato-κ2O,O′)samarium(III), C12H14N7O9Sm
- Crystal structure of hexaaqua-{(E)-N′-(1-(pyrazin-2-yl)ethylidene)isonicotinohydrazide-κ3N,N′,O}praseodym(III) trichloride monohydrate, C12H25Cl3N5O8Pr
- Crystal structure of methyl 4-(3-cyanophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C21H22N2O3
- Crystal structure of ethyl 2-amino-4-(2-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO6
- Crystal structure of 2,12-dibromo-5,15-dihexyl-5,15-dihydrobenzo [1,2-b:5,6-c′]dicarbazole, C38H38Br2N2
- Crystal structure of ethyl 2-amino-4-(3-hydroxy-4-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO7
- Crystal structure of ethyl 2-amino-4-(3,4-dimethylphenyl)-5-oxo-4H,5H-pyrano[3,2-c] chromene-3-carboxylate, C23H21NO5
- Crystal structure of 2-hydroxy-N′-(pyrimidin-2-yl)benzohydrazide, C11H10N4O2
- Crystal structure of 2-(3,4-dimethylphenyl)-1,8-naphthyridine, C16H14N2
- Crystal structure of ethyl 4-(3,4-dimethylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C23H29NO3
- Crystal structure of ethyl 4-(3-cyanophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C22H24N2O3
- Crystal structure of 7β,9β-dihydroxy-15-oxo-ent-kauran-16-en-19,6β-olide, C20H26O5
- Crystal structure of Ent-7β,20-epoxy-kaur-16-en-1β,6α,7α,14α,15α-pentaol-20-one, C20H30O8
- Crystal structure of 1,4-bis(benzo[d][1,3]dioxol-5-ylmethyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-yl acetate, C22H20O8
- Crystal structure of methyl 2-((4-((2-nitrophenoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl) benzoate, C18H16N4O5
- Crystal structure of diaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O)zinc(II), C12H14N4O10Zn
- Hydrothemal synthesis and crystal structure of triaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O;κ1O)manganese(II), C12H16N4O11Mn
- Redetermination of methyl 4-(4-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22ClNO3
- Crystal structure of bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-methyl-imdazol)-κN}-dithiocyano-κN-zinc(II) C24H22N12S2Zn
- Crystal structure of (5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl furan-2-carboxylate, C10H7FN2O5
- Crystal structure of bis(η6-cymene)-tri-μ2-chlorido-ruthenium(II) tetrafluoroborate, C20H28BCl3F4Ru2
- Crystal structure of 3,6-diphenyl-7H-[1,2,4]-triazolo[3,4-b][1,3,4]thiadiazine, C16H12N4S
- Synthesis and crystal structure of 1,3-bis[(3,4-dicyano)phenoxy]-4,6-dinitro-benzene, C22H8N6O6
- Crystal structure of ethyl 2-amino-4-(2,6-dichlorophenyl)-7-methyl-5-oxo-4H,5H-pyrano [4,3-b]pyran-3-carboxylate, C18H15Cl2NO5
- Crystal structure of poly[μ3-hydroxy-(μ5-(5-(2-carboxylatophenoxy)isophthalato-κ6O1:O2:O3:O4:O5,O6)-(μ2-1,4-di(1H-imidazol-1-yl)butane-κ2N:N′)dicobalt(II)] hemihydrate, C25H22Co2N4O8.5
- Crystal structure of methyl 4-(4-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C20H22BrNO3
- Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate trihydrate, C35H33NO12
- Crystal structure of 2,5-bis(4-(10H-phenothiazin-10-yl)phenyl)-1,3,4-oxadiazole, C38H24N4OS2
- The crystal structure of (E)-2-(4-hydroxyphenyl)-5-(prop-1-en-1-yl)benzofuran-3-carbaldehyde, C18H14O3
- Crystal structure of bis{5H-dibenzo[c,f][1,5]oxabismocin-12(7H)-yl} carbonate, C29H24O5Bi2
- Crystal structure of ethyl-5-formyl-3,4-dimethylpyrrole-2-carboxylate — N-(5-ethoxycarbonyl-3,4-dimethylpyrrole)-2-methylene-5-nitrobenzene-1,2-diamine (1:1), C26H31N5O7
- Crystal structure of (E)-2-(1-((2-aminophenyl)imino)ethyl)-6-bromo-4-chlorophenol, C14H12BrClN2O
- Crystal structure of (Z)-2-(4-chlorophenyl)-4-(furan-2-yl(phenylamino)methylene)-5-methyl-2,4-dihydro-3H-pyrazol-3-one, C21H16ClN3O2
- Crystal structure of N2,N4-dibutyl-6-chloro-N2,N4-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine, C31H58ClN7 – Important intermediate of Chimassorb 119 synthesis
- Crystal structure of 1-(5-bromo-2-(4-methoxyphenyl)-1H-indol-7-yl)ethanone oxime, C17H15BrN2O2
- Crystal structure of poly-{diaqua-bis[(μ2-3-nitrobenzenesulfonylglycine-κ3N:O:O′)(4,4′-bipyridine)manganese(II)]}-dimethylformamide (1/1), C39H35Mn2N9O15S2
- Crystal structure of 4-(dimethylamino)-1-(prop-2-yn-1-yl)pyridin-1-ium perchlorate, C10H13ClN2O4
- Crystal structure of 2-amino-5-oxo-4-(4-chloro-phenyl)-4,5,6,7-tetrahydro-cyclopenta[b]pyran-3-carbonitrile, C15H11ClN2O2
- Crystal structure of triaqua-(pyridine-2,6-dicarboxylato-κ3O,N,O′)cobalt(II) – 6-phenyl-1,3,5-triazine-2,4-diamine (1/1), C16H18CoN6O7
- Crystal structure of ethyl 2-amino-4-(3-cyanophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C21H22N2O4
- Crystal structure of 2-(4-chloro-2,6-dinitrophenyl)-1-(4-chloro-3-nitrophenyl)diazene 1-oxide, C12H5Cl2N5O7
- Crystal structure of 3,4-dimethyl-2,6-dinitrophenol, C8H8N2O5
- Crystal structure of 1,2-dimethyl-3,5-dinitrobenzene, C8H8N2O4
- Crystal structure of ethyl 4-(3-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C21H24ClNO3
- Crystal structure of N-(4-chlorophenyl)-2-(2,6-dichlorophenyl)acetamide, C14H10Cl3NO
- Crystal structure of 2-amino-4-(4-fluorophenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2c] chromene, C19H11FN2O3
- The crystal structure of (4-nitrophenyl) (5-ferrocenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl) methanone, C21H12F3FeN3O3
- Crystal structure of 5,5′-((3-hydroxy-4-methoxyphenyl)methylene)bis(1,3-diethyl-6-hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one), C24H30N4O6S2
- Crystal structure of (3aR,4R,5R,7R,8S,9R,9aS,12R)-7-ethyl-5-(1-hydroxy-2-((R)-3-hydroxypyrrolidin-1-yl)ethoxy)-4,7,9,12-tetramethyldecahydro-4,9a-propanocyclopenta[8]annulene-3,8-diol – a pleuromutilin derivative, C26H41NO5
- Crystal structure of bis(μ2-3-formyl-5-methoxy-2-oxidobenzoato-κ3O,O′:O′)-hexapyridine-dicadmium(II) – pyridine (1/1), C53H47Cd2N7O10
- Crystal structure of ethyl 2-amino-4-(3-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO6
- Crystal structure of methyl 4-(3,5-ditrifluoromethylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate — water (2/1), C22H21F6NO3
- Crystal structure of 2-(4-bromophenyl)-2,3-dihydro-1H-perimidine, C17H13BrN2
- Crystal structure of (5-ethyl-2-(4-methoxyphenyl)-1,3-dioxan-5-yl)methanol, C14H20O4
- Crystal structure of (E)-N-(4-bromo-2-(1-(hydroxyimino)ethyl)phenyl)benzamide, C15H13BrN2O2
- Crystal structure of caffeinium triiodide – caffeine (1/1), C16H21I3N8O4
- Crystal structure of methyl 2-methyl-4-(3-methoxyphenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C19H21NO4
- Crystal structure of (E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1-phenylprop-2-en-1-one, C23H28O2
- Crystal structure of 1,4-bis(2-azidoethyl)piperazine-1,4-diium dichloride, C8H18N8Cl2
- The crystal structure of dichlorido-(1,3-bis(2,6-dimethylphenyl)-1H-imidazol-2(3H)-ylidene)-(morpholine-κ1N)palladium(II), C23H29Cl2N3OPd(II)
- The crystal structure of 1-((5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-yl)methyl)-1,3-diphenylurea, C24H21ClN4O
- Crystal structure of 6-(2-bromoacetamido)tetrahydro-2H-pyran-2,3,4,5-Tetrayl tetraacetate, C16H22BrNO10
- Crystal structure of 5-methylpyrazine-2-carbohydrazide, C6H8N4O
- Crystal structure of catena-poly[(μ2-5-(tert-butyl)isophthalato-κ4O,O′:O′′,O′′′)(-4′-(pyridin-4-yl)-2,2′:6′,2′′-terpyridine-κ3N,N′,N′′)manganese(II)], C32H28N4O5Mn
Articles in the same Issue
- Cover and Frontmatter
- Crystal structure of 2-amino-4-(2,4-dinitrophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo-pyran, C18H16N4O6
- Crystal structure of catena-poly[(μ3-5-carboxy-2-(pyridin-4-yl)benzoato-κ5O,O′:O′′,O′′′:O′′′)(1,10-phenanthroline-κ2N,N′)cadmium(II)], C100H60N12O16Cd4
- Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-7-methyl-5-oxo-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C19H18N2O6
- Crystal structure of 1-{4-[(2-hydroxy-5-methyl benzylidene)amino]phenyl}ethanone O-ethyl-oxime, C18H20N2O2
- Crystal structure of bis{4-methyl-2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O)}copper(II), C36H38CuN4O4
- Crystal structure of bis{5-methoxy-2-((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}nickel(II), C34H34N4NiO6
- Crystal structure of poly[μ8-3-carboxyphthalat-κ8-O:O1,O1,O1:O2:O3,O3:O4)silver(I)], C9H4Ag2O6
- Crystal structure of 2-((E)-((4-((E)-1-(hydroxyimino)ethyl)phenyl)iminio)methyl)-5-methoxyphenolate, C16H16N2O3
- Crystal structure of (E)-1-(4-(((E)-2-hydroxy-3-methoxybenzylidene)amino)phenyl)ethan-1-one oxime, C16H16N2O3
- The crystal structure of 2-(tert-butyl)-4-chloro-6-phenyl-1,3,5-triazine, C13H14Cl1N3
- Crystal structure of (6,6′-(((((2-aminoethyl)azanediyl)bis(ethane-2,1-diyl))bis(azanylylidene))bis(methanylylidene))bis(2,4-dichlorophenolato)-κ6N,N′,N′′,N′′′,O,O′)cadmium(II) – ethanol – water (1/1/1), C22H28CdCl4N4O4
- Crystal structure of 6-chloro-N-methylpyrimidin-4-amine, C5H6ClN3
- Synthesis and crystal structure of bis{((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)-2-naphtholato-κ2N,O}nickel(II), C40H34N4NiO4
- Crystal structure of (E)-2-(4-bromophenyl)ethenesulfonyl fluoride (C8H6BrFO2S)
- Synthesis and crystal structure of 2,2′-ethylenedioxybis(benzimide)-2,2′-bis[O-(1-propyloxyamide)]oxime-4,4′,6,6′-tetrachlorodiphenol, C36H34Cl4N4O8
- Crystal structure of bis(N-(1-(pyrazin-2-yl)ethylidene)nicotinohydrazonato-κ3N,N′,O)cadmium(II) – methanol (1/1), C26H28N10O4Zn
- Crystal structure of diaqua-(N-(1-(pyrazin-2-yl)ethylidene)nicotinohydrazonato-κ3N,N′,O)-bis(nitrato-κ2O,O′)samarium(III), C12H14N7O9Sm
- Crystal structure of hexaaqua-{(E)-N′-(1-(pyrazin-2-yl)ethylidene)isonicotinohydrazide-κ3N,N′,O}praseodym(III) trichloride monohydrate, C12H25Cl3N5O8Pr
- Crystal structure of methyl 4-(3-cyanophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C21H22N2O3
- Crystal structure of ethyl 2-amino-4-(2-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO6
- Crystal structure of 2,12-dibromo-5,15-dihexyl-5,15-dihydrobenzo [1,2-b:5,6-c′]dicarbazole, C38H38Br2N2
- Crystal structure of ethyl 2-amino-4-(3-hydroxy-4-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO7
- Crystal structure of ethyl 2-amino-4-(3,4-dimethylphenyl)-5-oxo-4H,5H-pyrano[3,2-c] chromene-3-carboxylate, C23H21NO5
- Crystal structure of 2-hydroxy-N′-(pyrimidin-2-yl)benzohydrazide, C11H10N4O2
- Crystal structure of 2-(3,4-dimethylphenyl)-1,8-naphthyridine, C16H14N2
- Crystal structure of ethyl 4-(3,4-dimethylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C23H29NO3
- Crystal structure of ethyl 4-(3-cyanophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C22H24N2O3
- Crystal structure of 7β,9β-dihydroxy-15-oxo-ent-kauran-16-en-19,6β-olide, C20H26O5
- Crystal structure of Ent-7β,20-epoxy-kaur-16-en-1β,6α,7α,14α,15α-pentaol-20-one, C20H30O8
- Crystal structure of 1,4-bis(benzo[d][1,3]dioxol-5-ylmethyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-yl acetate, C22H20O8
- Crystal structure of methyl 2-((4-((2-nitrophenoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl) benzoate, C18H16N4O5
- Crystal structure of diaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O)zinc(II), C12H14N4O10Zn
- Hydrothemal synthesis and crystal structure of triaqua-bis(5-carboxy-1-methyl-1H-imidazole-4-carboxylato-κ2N,O;κ1O)manganese(II), C12H16N4O11Mn
- Redetermination of methyl 4-(4-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22ClNO3
- Crystal structure of bis{1-[(benzotriazol-1-yl)methyl]-1-H-1,3-(2-methyl-imdazol)-κN}-dithiocyano-κN-zinc(II) C24H22N12S2Zn
- Crystal structure of (5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl furan-2-carboxylate, C10H7FN2O5
- Crystal structure of bis(η6-cymene)-tri-μ2-chlorido-ruthenium(II) tetrafluoroborate, C20H28BCl3F4Ru2
- Crystal structure of 3,6-diphenyl-7H-[1,2,4]-triazolo[3,4-b][1,3,4]thiadiazine, C16H12N4S
- Synthesis and crystal structure of 1,3-bis[(3,4-dicyano)phenoxy]-4,6-dinitro-benzene, C22H8N6O6
- Crystal structure of ethyl 2-amino-4-(2,6-dichlorophenyl)-7-methyl-5-oxo-4H,5H-pyrano [4,3-b]pyran-3-carboxylate, C18H15Cl2NO5
- Crystal structure of poly[μ3-hydroxy-(μ5-(5-(2-carboxylatophenoxy)isophthalato-κ6O1:O2:O3:O4:O5,O6)-(μ2-1,4-di(1H-imidazol-1-yl)butane-κ2N:N′)dicobalt(II)] hemihydrate, C25H22Co2N4O8.5
- Crystal structure of methyl 4-(4-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C20H22BrNO3
- Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate trihydrate, C35H33NO12
- Crystal structure of 2,5-bis(4-(10H-phenothiazin-10-yl)phenyl)-1,3,4-oxadiazole, C38H24N4OS2
- The crystal structure of (E)-2-(4-hydroxyphenyl)-5-(prop-1-en-1-yl)benzofuran-3-carbaldehyde, C18H14O3
- Crystal structure of bis{5H-dibenzo[c,f][1,5]oxabismocin-12(7H)-yl} carbonate, C29H24O5Bi2
- Crystal structure of ethyl-5-formyl-3,4-dimethylpyrrole-2-carboxylate — N-(5-ethoxycarbonyl-3,4-dimethylpyrrole)-2-methylene-5-nitrobenzene-1,2-diamine (1:1), C26H31N5O7
- Crystal structure of (E)-2-(1-((2-aminophenyl)imino)ethyl)-6-bromo-4-chlorophenol, C14H12BrClN2O
- Crystal structure of (Z)-2-(4-chlorophenyl)-4-(furan-2-yl(phenylamino)methylene)-5-methyl-2,4-dihydro-3H-pyrazol-3-one, C21H16ClN3O2
- Crystal structure of N2,N4-dibutyl-6-chloro-N2,N4-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine, C31H58ClN7 – Important intermediate of Chimassorb 119 synthesis
- Crystal structure of 1-(5-bromo-2-(4-methoxyphenyl)-1H-indol-7-yl)ethanone oxime, C17H15BrN2O2
- Crystal structure of poly-{diaqua-bis[(μ2-3-nitrobenzenesulfonylglycine-κ3N:O:O′)(4,4′-bipyridine)manganese(II)]}-dimethylformamide (1/1), C39H35Mn2N9O15S2
- Crystal structure of 4-(dimethylamino)-1-(prop-2-yn-1-yl)pyridin-1-ium perchlorate, C10H13ClN2O4
- Crystal structure of 2-amino-5-oxo-4-(4-chloro-phenyl)-4,5,6,7-tetrahydro-cyclopenta[b]pyran-3-carbonitrile, C15H11ClN2O2
- Crystal structure of triaqua-(pyridine-2,6-dicarboxylato-κ3O,N,O′)cobalt(II) – 6-phenyl-1,3,5-triazine-2,4-diamine (1/1), C16H18CoN6O7
- Crystal structure of ethyl 2-amino-4-(3-cyanophenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C21H22N2O4
- Crystal structure of 2-(4-chloro-2,6-dinitrophenyl)-1-(4-chloro-3-nitrophenyl)diazene 1-oxide, C12H5Cl2N5O7
- Crystal structure of 3,4-dimethyl-2,6-dinitrophenol, C8H8N2O5
- Crystal structure of 1,2-dimethyl-3,5-dinitrobenzene, C8H8N2O4
- Crystal structure of ethyl 4-(3-chlorophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C21H24ClNO3
- Crystal structure of N-(4-chlorophenyl)-2-(2,6-dichlorophenyl)acetamide, C14H10Cl3NO
- Crystal structure of 2-amino-4-(4-fluorophenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2c] chromene, C19H11FN2O3
- The crystal structure of (4-nitrophenyl) (5-ferrocenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl) methanone, C21H12F3FeN3O3
- Crystal structure of 5,5′-((3-hydroxy-4-methoxyphenyl)methylene)bis(1,3-diethyl-6-hydroxy-2-thioxo-2,3-dihydropyrimidin-4(1H)-one), C24H30N4O6S2
- Crystal structure of (3aR,4R,5R,7R,8S,9R,9aS,12R)-7-ethyl-5-(1-hydroxy-2-((R)-3-hydroxypyrrolidin-1-yl)ethoxy)-4,7,9,12-tetramethyldecahydro-4,9a-propanocyclopenta[8]annulene-3,8-diol – a pleuromutilin derivative, C26H41NO5
- Crystal structure of bis(μ2-3-formyl-5-methoxy-2-oxidobenzoato-κ3O,O′:O′)-hexapyridine-dicadmium(II) – pyridine (1/1), C53H47Cd2N7O10
- Crystal structure of ethyl 2-amino-4-(3-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C22H19NO6
- Crystal structure of methyl 4-(3,5-ditrifluoromethylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate — water (2/1), C22H21F6NO3
- Crystal structure of 2-(4-bromophenyl)-2,3-dihydro-1H-perimidine, C17H13BrN2
- Crystal structure of (5-ethyl-2-(4-methoxyphenyl)-1,3-dioxan-5-yl)methanol, C14H20O4
- Crystal structure of (E)-N-(4-bromo-2-(1-(hydroxyimino)ethyl)phenyl)benzamide, C15H13BrN2O2
- Crystal structure of caffeinium triiodide – caffeine (1/1), C16H21I3N8O4
- Crystal structure of methyl 2-methyl-4-(3-methoxyphenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C19H21NO4
- Crystal structure of (E)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1-phenylprop-2-en-1-one, C23H28O2
- Crystal structure of 1,4-bis(2-azidoethyl)piperazine-1,4-diium dichloride, C8H18N8Cl2
- The crystal structure of dichlorido-(1,3-bis(2,6-dimethylphenyl)-1H-imidazol-2(3H)-ylidene)-(morpholine-κ1N)palladium(II), C23H29Cl2N3OPd(II)
- The crystal structure of 1-((5-chloro-3-methyl-1-phenyl-1H-pyrazole-4-yl)methyl)-1,3-diphenylurea, C24H21ClN4O
- Crystal structure of 6-(2-bromoacetamido)tetrahydro-2H-pyran-2,3,4,5-Tetrayl tetraacetate, C16H22BrNO10
- Crystal structure of 5-methylpyrazine-2-carbohydrazide, C6H8N4O
- Crystal structure of catena-poly[(μ2-5-(tert-butyl)isophthalato-κ4O,O′:O′′,O′′′)(-4′-(pyridin-4-yl)-2,2′:6′,2′′-terpyridine-κ3N,N′,N′′)manganese(II)], C32H28N4O5Mn